Cardiovascular proteomics is a specialized branch of proteomics that focuses on the comprehensive study of proteins involved in cardiovascular health and disease. Proteomics, the large-scale analysis of proteins, plays a crucial role in unraveling the complex molecular mechanisms underlying cardiovascular conditions such as heart disease and stroke. By examining the complete set of proteins present in the cardiovascular system, researchers aim to identify biomarkers for early disease detection, understand the pathways involved in disease progression, and discover potential therapeutic targets. The application of advanced mass spectrometry and other high-throughput technologies enables the systematic analysis of protein expression, post-translational modifications, and interactions within the intricate network of proteins associated with the cardiovascular system. The insights gained from cardiovascular proteomics not only deepen our understanding of the molecular basis of cardiovascular diseases but also pave the way for the development of innovative diagnostic tools and targeted therapies, ultimately contributing to improved patient outcomes in the realm of cardiovascular health.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China